China Biotech Services Holdings Limited (Stock Code: 08037) has released its monthly return as of 31 October 2025. The announcement confirms that the authorized share capital remains at 2,000,000,000 ordinary shares, with a par value of HK$0.1 each, totaling HK$200,000,000. The number of issued shares stands at 975,731,150, showing no change from the previous month.

Regarding convertible bonds issued on 27 December 2024 in the principal amount of US$6,000,000, the Company indicates that a maximum of 39,250,000 ordinary shares could be issued upon full conversion, based on an initial conversion price of HK$1.20 per share and an exchange rate of HK$7.85 to US$1.00. The announcement also notes that convertible bonds totaling US$10,000,000 were previously surrendered and canceled. No other adjustments to the Company’s share structure or treasury shares were reported for October 2025.